Cargando…
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
BACKGROUND: Antenatal magnesium sulphate, widely used in obstetrics to improve maternal and infant outcomes, may be associated with adverse effects for the mother sufficient for treatment cessation. This systematic review aimed to quantify maternal adverse effects attributed to treatment, assess how...
Autores principales: | Bain, Emily S, Middleton, Philippa F, Crowther, Caroline A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015216/ https://www.ncbi.nlm.nih.gov/pubmed/24139447 http://dx.doi.org/10.1186/1471-2393-13-195 |
Ejemplares similares
-
Antenatal magnesium sulphate and adverse neonatal outcomes: A
systematic review and meta-analysis
por: Shepherd, Emily, et al.
Publicado: (2019) -
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework
por: Bain, Emily, et al.
Publicado: (2015) -
Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis
por: Crowther, Caroline A., et al.
Publicado: (2017) -
School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants
por: Kobayashi, Akira, et al.
Publicado: (2023) -
Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol
por: Crowther, Caroline A, et al.
Publicado: (2013)